Achieve Life Sciences appoints Kaitlyn Tuson as SVP of marketing
Seattle and Vancouver, British Columbia - Achieve Life Sciences Inc. has named Kaitlyn Tuson as Senior Vice President of Marketing and Communications, according to their press release. As the company gears up for the possible commercialization of cytisinicline, a potential treatment for nicotine addiction, Tuson will oversee marketing strategies, brand development, and corporate communications.
With 15 years of experience in healthcare brand creation and involvement in numerous pharmaceutical product launches across more than 40 therapeutic areas, Tuson's expertise is highly sought after. The move aligns with Achieve's plans to resubmit a New Drug Application for cytisinicline, which is currently in Phase 3 studies for smoking cessation and a long-term safety study for nicotine cessation.
Tuson will focus on educating patients, healthcare professionals, and other stakeholders about nicotine dependence as a treatable condition. Achieve Life Sciences has undergone several organizational changes in 2026, including CEO appointment, securing up to $354 million in financing, and adding senior leadership in commercial, manufacturing, and quality sectors.
An estimated 25 million adults in the United States smoke traditional cigarettes, while nearly 18 million use e-cigarettes, both groups currently lacking FDA-approved cessation treatments. Cytisinicline is a plant-derived alkaloid that targets nicotine receptors in the brain.
Rewritten by urgent.news; may contain errors — check the original.